24 results
6-K/A
EX-99.5
OBSVF
ObsEva SA
13 Oct 21
ObsEva Announces Relationship with Syneos Health to Commercialize Linzagolix
5:24pm
they receive compensation. In connection with sales of the shares of Common Stock or otherwise, the selling shareholders may enter into hedging transactions … with broker-dealers, which may in turn engage in short sales of the shares of Common Stock in the course of hedging in positions they assume
6-K
EX-99.5
OBSVF
ObsEva SA
13 Oct 21
ObsEva Announces Relationship with Syneos Health to Commercialize Linzagolix
9:27am
they receive compensation. In connection with sales of the shares of Common Stock or otherwise, the selling shareholders may enter into hedging transactions … with broker-dealers, which may in turn engage in short sales of the shares of Common Stock in the course of hedging in positions they assume
6-K/A
EX-99.2
OBSVF
ObsEva SA
13 Oct 21
ObsEva Announces Relationship with Syneos Health to Commercialize Linzagolix
5:24pm
Purchasers may sell Conversion Shares or Warrant Shares or engage in hedging activities at various times during the period that the Securities … are outstanding and (z) such sales or hedging activities (if any) may negatively affect the Company’s stock price, including during the Measurement Period
6-K
EX-99.3
OBSVF
ObsEva SA
28 Jan 22
ObsEva Announces Corporate Updates
5:16pm
and acknowledges that (y) one or more Purchasers may sell Conversion Shares or Warrant Shares or engage in hedging activities at various times during … the period that the Securities are outstanding and (z) such sales or hedging activities (if any) may negatively affect the Company’s stock price
6-K
EX-99.2
OBSVF
ObsEva SA
13 Oct 21
ObsEva Announces Relationship with Syneos Health to Commercialize Linzagolix
9:27am
agreements, interest rate hedging agreements, interest rate swaps or other financial products, in each case, to the extent the foregoing would appear … that (y) one or more Purchasers may sell Conversion Shares or Warrant Shares or engage in hedging activities at various times during the period
424B7
9j3yfrs
23 Nov 21
Prospectus with selling stockholder info
4:06pm
424B7
fc2 jjqz5a8
3 Mar 22
Prospectus with selling stockholder info
4:43pm
F-3
60qlw21jz jc8ulnucl
10 Nov 21
Shelf registration (foreign)
5:23pm
F-3
m3jhn6 whmfelr
17 Feb 22
Shelf registration (foreign)
4:14pm
10-K
1af17uq98lg v46
31 Mar 23
Annual report
4:01pm
424B5
3tj8 hpjo
5 Mar 21
Prospectus supplement for primary offering
7:55am
424B5
z7rzjf erbfxuyj
18 Jun 18
Prospectus supplement for primary offering
9:15pm
424B5
nu3o8r dqccrl1xot
7 Aug 19
Prospectus supplement for primary offering
8:18am
DRS
tg7dof ljzkg
14 Oct 16
Draft registration statement
12:00am
424B5
31qa62
20 Jun 18
Prospectus supplement for primary offering
5:32pm
6-K
EX-99.1
y0wps
7 Aug 19
Current report (foreign)
7:21am
F-1
k7ptp3qln8n b8uw
30 Dec 16
Registration statement (foreign)
12:00am